Singapore has come under the spotlight in a US investigation into whether Chinese artificial intelligence (AI) start-up DeepSeek had circumvented US restrictions on advanced Nvidia chips by ...

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name ...

The global trade system has been profoundly reshaped since US President Donald Trump’s ... according to a new report by McKinsey. The findings raise pressing questions about how Trump may ...

to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid epidemic. The deal comes after the US Supreme Court last year rejected a $6 ...

Connecticut, New York and 13 other states have announced a tentative $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, for their role in the opioid crisis.

"Purdue, under the Sacklers' leadership, invented, manufactured and aggressively marketed opioid products for decades, fueling waves of addiction and overdose deaths across the country," James said in ...

Advertisement "Purdue, under the Sacklers' leadership, invented, manufactured and aggressively marketed opioid products for decades, fueling waves of addiction and overdose deaths across the ...

“Protecting consumers’ personal information and maintaining a secure platform is a top priority for us and we take our regulatory responsibilities seriously," a company spokesperson told ...

Since then, opioids have been linked to hundreds of thousands of overdose deaths in the US. The deadliest stretch has been since 2020 when the illicit synthetic opioid fentanyl was found to be a ...

BOSTON — Massachusetts and other states have reached a tentative $7.4 billion settlement with the Sackler family and Purdue Pharma over their alleged role in fueling the nation’s opioid crisis.

have increased their cash offer to settle the litigation — but with a novel catch. Under the framework for a new deal, the Sacklers would not receive immunity from future opioid lawsuits ...